Organization: Health Canada
Year: 2023
Month: March
Request Number: A-2022-000144
Request Summary: All adverse reaction reports, excluding foreign reports, where olanzapine, as the active ingredient is listed as the suspect medication for individuals aged 65 and older between the dates of January 1, 1997 to April 27, 2021.
Disposition: Disclosed in part
Number of pages: 2070